The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk that ...

Government health advisers Thursday called for restrictions on some long-acting asthma drugs, but spared Advair, a top-selling medication used by millions of patients. Government health advisers ...

GlaxoSmithKline is shifting its sales strategy for therapy Advair to stress increasing a treatment for chronic obstructive pulmonary disease (COPD), a new report states.Advair, a long-acting beta2 ...

LONDON, June 4 (Reuters) - AstraZeneca Plc is seeking U.S. approval to market its asthma drug Symbicort as a treatment for young children, increasing the competitive pressure on GlaxoSmithKline Plc's ...

Surveyed Physicians Who Identified Advair/Seretide/Adoair or Symbicort As the Most Efficacious Asthma Therapy Indicate High Levels of Satisfaction Across All Efficacy Attributes, According to Findings ...

Mylan is inching closer toward its FDA decision date for generic Advair. But thanks to some crafty payer negotiating from GlaxoSmithKline, it may be a while before Mylan's knockoff can gain serious ...

GSK and Theravance scored a win Wednesday when an FDA reviewing committee voted to recommend approval of their COPD drug Breo, which combines fluticasone furoate and vilanterol. The panel voted on a ...

It's no secret that respiratory drugs make up a crowded field, and forthcoming generics will make the competition tougher still. AstraZeneca's Symbicort is no stranger to the fallout, either, what ...

WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...

Government health advisers recommended restrictions Thursday on some long-acting asthma drugs, although not Advair, a top-selling medication. Outside experts advising the Food and Drug Administration ...

The government is taking steps to curb use of some long-acting asthma drugs used by millions, issuing safety restrictions Thursday to lower a life-threatening risk that asthma could worsen suddenly.

WASHINGTON The Food and Drug Administration has approved GlaxoSmithKline’s asthma drug Advair to be used more widely to treat patients with chronic obstructive pulmonary disease, according to ...